What the company does
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally. The company's lead product candidates include HDP-101, an anti-BCMA antibody, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It also develops HDP-102, an antibody and the compound Amanitin, which has completed preclinical development for the treatment of non-Hodgkin lymphoma; HDP-103, a proprietary ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for the treatment of gastrointestinal tumors; HDP-201 for the treatment of colorectal cancer; …
What the weekly tape is saying
HPHA closed the latest completed week at 2.58 EUR. The 4-week return is -7.5% and the 12-week return is -12.8%. Trend Signal is inactive, Market Dynamics is -0.69. Setup signature: Risk-first tape with a 21/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2.84 EUR
- Vs Trend Line
- -9.3%
- Fair Value
- 3.04 EUR
- Vs Fair Value
- -15.1%
- 52W High
- 4.97 EUR
- 52W Low
- 2.33 EUR
- Drawdown
- -48.1%
- Range Position
- 9.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 13
- 52W Active Breadth
- 25.0%
- Sector Scope
- DE Healthcare
- Sector Rank
- 67 of 80
- Sector Percentile
- 16.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
DE Healthcare
- Tracked Peers
- 80
- 4W Rank
- 66 of 80
- Avg 1W
- -1.6%
- Avg 4W
- 1.1%
- Trend Breadth
- 32.5%
- Positive MD
- 43.8%
DE Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 8 of 12
- Avg 1W
- -3.8%
- Avg 4W
- -6.8%
- Trend Breadth
- 25.0%
- Positive RS
- 16.7%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.69
- 4W MD Change
- -52.7%
- Relative Strength
- -21.75
- 4W RS Change
- -38.5%
- Expectation
- Negative
- Probability
- 36.35%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 20.6K
- 13W Average
- 14.5K
- 52W Average
- 33.6K
- Vs 13W
- 1.4x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.0%
- 52W Volatility
- 7.0%
- Upside Weeks
- 21
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 4.7% / -4.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- GER
- Country
- DE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 124.9M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.58 EUR | -4.4% | 2.84 EUR | 3.04 EUR | -0.69 | -21.75 | 20.6K | Off |
| 5 Jun 2026 | 2.70 EUR | 1.1% | 2.86 EUR | 3.04 EUR | -0.56 | -19.41 | 24.5K | Off |
| 29 May 2026 | 2.67 EUR | -4.3% | 2.87 EUR | 3.05 EUR | -0.56 | -22.36 | 23.7K | Off |
| 22 May 2026 | 2.79 EUR | 0.0% | 2.88 EUR | 3.06 EUR | -0.52 | -18.56 | 7.8K | Off |
| 15 May 2026 | 2.79 EUR | 2.2% | 2.89 EUR | 3.07 EUR | -0.45 | -15.70 | 4.7K | Off |
| 8 May 2026 | 2.73 EUR | -3.9% | 2.90 EUR | 3.07 EUR | -0.52 | -19.04 | 7.4K | Off |
| 1 May 2026 | 2.84 EUR | 2.9% | 2.91 EUR | 3.08 EUR | -0.41 | -15.87 | 221 | Off |
| 24 Apr 2026 | 2.76 EUR | 0.4% | 2.92 EUR | 3.09 EUR | -0.16 | -17.82 | 39.2K | Off |
| 17 Apr 2026 | 2.75 EUR | 0.0% | 2.93 EUR | 3.10 EUR | 0.06 | -20.16 | 17.3K | Off |
| 10 Apr 2026 | 2.75 EUR | -7.4% | 2.95 EUR | 3.11 EUR | 0.35 | -17.28 | 19.4K | Off |
| 3 Apr 2026 | 2.97 EUR | -1.7% | 2.98 EUR | 3.12 EUR | 0.65 | -8.35 | 1.5K | Off |
| 27 Mar 2026 | 3.02 EUR | 2.0% | 2.99 EUR | 3.12 EUR | 0.71 | -3.29 | 6.3K | Off |
| 20 Mar 2026 | 2.96 EUR | -2.3% | 3.02 EUR | 3.13 EUR | 0.67 | -5.42 | 15.3K | Off |
| 13 Mar 2026 | 3.03 EUR | -1.3% | 3.06 EUR | 3.14 EUR | 0.66 | -7.38 | 87.0K | Off |